hydroxyurea - Generic mfg.
Besremi (ropeginterferon alfa-2b-njft) - PharmaEssentia
bomedemstat (MK-3543) - Merck (MSD)
Jakafi (ruxolitinib) - Incyte
ViraferonPeg (peginterferon-α-2b) - Merck (MSD)
A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025) (clinicaltrials.gov) - Sep 28, 2026 - P2/3 | N=380 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting 
Enrollment open • Polycythemia Vera
http://clinicaltrials.gov/ct2/show/NCT07722611
 
Sep 28, 2026
 
Prev Next